Related Experiment Video
Updated: May 20, 2026

Optimized Analysis of Proteins from Xenopus Oocytes and Embryos by Immunoblotting
Published on: September 19, 2025
The RNA- and DNA-Binding Protein Y-Box Binding Protein 1 (YB-1) Regulates iNKT Cell Development
Silvia Schulze1,2, Laura Knop1,2, Nouria Jantz-Naeem1,2
1Institute of Clinical Immunology and Cell Therapeutics, Medical Faculty, Otto-von-Guericke-University Magdeburg, Magdeburg, Germany.
Abstract:
Y-box binding protein 1 (YB-1) is a multifunctional RNA- and DNA-binding protein with broad regulatory functions in gene expression, particularly at the posttranscriptional level. Here, we demonstrate that conditional deletion of YB-1 at the double-positive (DP) thymocyte stage causes an ∼80% reduction of invariant natural killer T (iNKT) cells in thymus, spleen, and liver, evident already in day-14 neonates and persisting into adulthood. Our data reveal CD44-NK1.1- stage 1 accumulation and a selective loss of CD44+NK1.1+ stage 3 iNKT cells, indicating a postselection maturation defect. All iNKT cell subsets (iNKT1, iNKT2, iNKT17) were reduced, with thymic iNKT1 and splenic iNKT17 cells most severely affected. PMA/ionomycin-stimulated YB-1-deficient iNKT cells showed preserved IFN-γ+/IL-4+ frequencies but reduced per-cell cytokine production and a loss of IL-17 production. Interestingly, YB-1KO DP thymocytes showed increased CD1d levels, suggesting increased TCR signal strength in the thymus of YB-1-deficient mice. Whereas CD5 levels were elevated, basal Nur77, ICOS, and CD122 (IL-15Rβ) expression were reduced in iNKT cells. Furthermore, apoptosis was increased, particularly at iNKT stages 2-3. Together, these findings identify YB-1 as a central regulator of iNKT cell development that integrates TCR, co-stimulatory, and IL-15 signaling to ensure postselection iNKT cell maturation, effector subset specification, and survival.
Related Concept Videos
Negative Regulator Molecules
Inheritance of Chromatin Structures
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Methods of Nuclear Reprogramming
RNA Polymerase II Accessory Proteins
Master Transcription Regulators

